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Classical overtraining syndrome
The Olympic motto citius, altius, fortius (faster, higher, strong-
er) epitomises the goal of athletic training.  As athletes strive 
to improve their performance, inevitably their training load in-
creases.  Frequently their training strategies are successful 
and their performance improves.  However, substantial an-
ecdotal as well as experimental evidence17,18 links intensified 
training, for an extended period, with a chronic decrement in 
athletic performance. This reduced performance may mani-
fest as an athlete failing to improve/maintain his/her previous 
performances, despite undergoing more intensive training, or 
an athlete reporting an inability to regain previous form fol-
lowing a vigorous competition.  
Athletes must undergo significant amounts of physiological 
as well as psychological stress during training in order to 
provide sufficiently potent stimuli for appropriate adaptations 
to occur.  To ensure that the athlete adapts favourably to 
the training load imposed, adequate rest is a crucial part 
of any training programme.  If rest is not sufficient and the 
exercise stress alone or combined with other stressors 
(health, nutritional, environmental or psychological) is too 
great, the athlete may fail to adapt (maladapt) and enter a 
state of ‘overreaching’.  If the athlete continues training with 
insufficient rest, and in addition is exposed to further stressors 
(mentioned above), then a state of chronic underperformance 
may occur.  This condition has been referred to as overtraining 
syndrome (OTS), but has also been referred to as staleness 
or burnout syndrome.22
It should be noted that although the condition of 
‘overreaching’ may be a precursor to overtraining, certain 
coaches and athletes regard this condition as an integral part 
of training to achieve a supercompensatory effect.22 However, 
if an athlete is overreached, approximately 2 weeks of rest 
should result in a return to previous performance levels or 
even improved performance.22 In contrast, the OTS athlete 
will not recover in 2 weeks.  It may take months for this 
athlete to recover, and in some instances the individual may 
never recover.22
OTS is commonly reported to occur in around 10 - 20% 
of elite endurance athletes32 and affects up to 65% of long-
distance runners at some point in their athletic career.28 This 
condition should therefore not be regarded as a marginal 
problem but as an important and frequent event in the athletic 
community.22  
Redefinition of overtraining syndrome 
Although the aetiology of OTS remains elusive the term 
‘overtraining syndrome’ may be a misnomer, since it implies 
that exercise is the sole causative factor of the syndrome. 
The recent redefinition of the syndrome focuses not only on 
the outcome, but also implies that the cause may be multi-
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The underperformance syndrome (UPS), previously known 
as the overtraining syndrome (OTS), has been defined as 
a persistent decrement in athletic performance capacity 
despite 2 weeks of relative rest. Clinical research has sug-
gested that cytokines play a key role in fatigue in disease 
and chronic fatigue syndrome.  Furthermore, it has re-
cently been demonstrated that exogenous administration 
of interleukin-6 (IL-6) increases the sensation of fatigue 
during exercise. In light of current cytokine and chronic fa-
tigue syndrome research, this article reviews and updates 
the cytokine theories that attempt to explain the aetiology 
of the debilitating fatigue experienced in OTS/UPS.  Ini-
tially, it was proposed that UPS may be caused by exces-
sive cytokine release during and following exercise, caus-
ing a chronic inflammatory state and ‘cytokine sickness’. 
More recently, the hypothesis was extended and it was 
proposed that time-dependent sensitisation could provide 
a model through which the aetiology of UPS may be ex-
plained. According to this model, the principal abnormal 
factor in UPS is an intolerance/heightened sensitivity to 
IL-6 during exercise.
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factorial39 being triggered by an accumulation of either sport 
and/or non-sport-related stress.29,43 Factors associated with 
the development of OTS may include extremely high loads of 
training with insufficient rest18 and/or excessive psychologi-
cal stress29 and/or illness.29 In order to reflect the multidimen-
sional nature of OTS, it is proposed that the broader term 
‘underperformance syndrome’ (UPS) be adopted instead of 
OTS.7  Similar to the previous definition, UPS is defined as 
a persistent decrement in athletic performance, despite 2 
weeks of relative rest, confirmed by both coach and athlete.7 
The primary difference in the terminology is that UPS focuses 
on the final outcome of the condition, namely underperform-
ance, whereas OTS focused on a single causative factor, 
namely the training load.  UPS is the acronym that will be 
used in this article.  
Behavioural and mood-related signs and symp-
toms of UPS  
Fatigue appears to be the most prominent and debilitating 
symptom of UPS.12  Specific fatigue-related symptoms re-
ported by UPS athletes include feeling continuously tired de-
spite adequate rest, as well as waking tired and unrefreshed 
despite an adequate duration of undisturbed sleep.12 In addi-
tion to these generalised reports of fatigue, the athlete com-
plains extensively of local fatigue usually in the exercising 
muscles, and frequently describes the feeling of ‘heavy legs’ 
during exercise.12  
Apart from the common symptom of persistent fatigue, 
a plethora of fatigue-related signs and symptoms have 
been associated with UPS, as is comprehensively detailed 
by Fry et al.14 Predominant symptoms include: (i) general 
malaise/flu-like symptoms; (ii) reduced interest in training 
and competing; (iii) reduced concentration; (iv) reduced 
socialising; (v) increased daytime sleepiness and waking 
unrefreshed; (vi) reduced appetite; and (vii) depression.
Many of the above symptoms may in fact be related to 
an underlying depression since many of these features, 
including fatigue, reflect classic neurovegetative features of 
depression.1 However, the issue of whether or not the UPS 
athlete is suffering from depression per se, remains somewhat 
controversial.  Morgan and colleagues31 have suggested that 
many UPS athletes suffer from what appears to be clinical 
depression and that frequently depression is the first sign 
of UPS, but is often ignored if the athlete is still performing 
adequately.  In support of the presence of depression, 
Armstrong and VanHeest2 have suggested that this could 
well be the underlying cause of OTS and recommend the use 
of antidepressants to treat UPS. Uusitalo et al.46 also support 
the notion of depression being associated with UPS.  
It has also been postulated6,12 that clinical depression is 
not a commonly reported sign of UPS.  These researchers 
have postulated that when depression is present, rather 
than being a cause of UPS, it may occur at a later stage 
as a consequence of UPS, due to the frustration the athlete 
experiences as a consequence of underperformance.
Thus many questions exist concerning the association 
between UPS and depression.  Questions include whether or 
not depression actually occurs, and if it does, what is the time 
point of onset of depression (does this precede the reduction 
in performance or is it a consequence); and what is the degree 
of depression (mild/moderate/severe).  An additional issue is 
whether or not depression is a separate symptom or part of a 
more extensive syndrome, ‘sickness behaviour’,41 which will 
be discussed in the next section.19,37 Lastly, important from 
the perspective of this article is that if depression does exist, 
is the fatigue experienced during UPS part of the depressed 
symptomology or is the fatigue a symptom in and of itself.
Communication of the sensation of fatigue from 
body to brain 
The cytokine hypothesis of overtraining syndrome 
The universal and most debilitating symptom in UPS is the 
persistent fatigue reported by athletes.  A hypothesis that at-
tempts to explain some of these fatigue-associated  mood/
behaviour changes is the ‘cytokine hypothesis of overtrain-
ing’.43 This proposes that intense and frequent training/com-
peting, over an extended period, with insufficient rest/re-
covery time, may result in exercise-induced tissue trauma. 
It was further suggested that this diffuse tissue trauma may 
evoke a chronic, systemic inflammatory response.13 Chronic 
inflammation is a complex event and, amongst other seque-
lae, there is increased synthesis of pleiotropic proteins, viz. 
cytokines, produced by many eukaryotic cells.  Cytokines 
may be grouped into several different families based on 
structure and/or function, such as anti- and pro-inflammatory 
cytokines.  The pro-inflammatory cytokines, which appear to 
be associated with chronic inflammation, include interleukin 
(IL)-1β, IL-6 and/or tumour necrosis factor-α (TNFα).13 It was 
further hypothesised that elevated circulating levels of any of 
these circulating cytokines could account for the many pre-
viously noted signs and symptoms of UPS, since cytokines 
have been shown to trigger alterations in immune, metabolic, 
physiological and behavioural responses.9,10,13 Although it 
was suggested that the primary source of serum cytokines 
was due to tissue trauma, it was also acknowledged that 
other factors such as illness, could initiate elevations in pe-
ripheral cytokine levels.
For a long while researchers have known that ‘information’ 
from the central nervous system (CNS) can be transmitted to 
the periphery of the body, via the sympathetic nervous system 
and/or the hypothalamic pituitary axis.27 However, the manner 
in which peripheral body-events, such as infection or injury, 
can ‘inform’ the CNS, has only recently been elucidated.  It 
is now clear that cytokines function as messenger molecules 
that can access the CNS from the periphery. This may 
occur via neural and/or humoral routes.10 It should be 
noted that cytokines may also be produced in the CNS and 
subsequently released into the peripheral circulation.41 This 
circular, interconnected, reverberating mind-body interaction 
forms the basis of psychoneuroimmunology.41 
Once within the CNS, IL-1β, IL-6 and TNFα are capable 
of activating specific brain structures, resulting in the 
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manifestation of a constellation of behaviours referred to 
as ‘sickness behaviour’ or ‘recuperative behaviour’.19,37 
This cluster of behaviours includes the following signs and 
symptoms: weakness, malaise, listlessness, and inability 
to concentrate.19,37 Additionally, individuals are somewhat 
depressed and lethargic, showing little interest in their 
surroundings.19,37 Much of this is similar to what has been 
described in UPS.14
Similarly to what Hans Selye described as a generalised 
stress response, which occurs in response to a variety 
of different stressors,42 this sickness behaviour may be 
regarded as a generalised response to illness and/or injury, 
and may also be induced by a variety of pathogens and/or 
tissue trauma.  Initially sickness behaviour was regarded as 
an unimportant, inconvenient by-product of sickness/injury. 
However, it is now recognised that it represents a highly 
organised, motivated strategy used to fight infection/illness 
so as to optimise healing/recovery from trauma.19,37 
In summary, the cytokine hypothesis suggests that any 
of the pro-inflammatory cytokines (IL-1β, and/or IL-6 and/
or TNFα) that may be produced by excessive training with 
insufficient rest and subsequent tissue trauma, may be 
responsible for many of the psychological changes including 
the extreme fatigue seen in UPS.
Interleukin-6 fatigue hypothesis of UPS 
Although the cytokine hypothesis of OTS could account for 
different aetiologies of OTS, such as psychological stress or 
Epstein-Barr virus,43 the emphasis was on excessive train-
ing/competing with insufficient rest/recovery and subsequent 
tissue trauma being the primary initiator.  Furthermore, the 
author proposed several pro-inflammatory cytokines being 
implicated in UPS, including IL-1β and TNFα.  Although these 
2 cytokines may ultimately be implicated in UPS, substan-
tially more research has been done pertaining to exercise 
and IL-6, as well as fatigue and IL-6, hence the ‘interleukin-6 
hypothesis of UPS’.39 The IL-6 hypothesis emphasises that 
factors aside from exercise-induced tissue trauma, trigger a 
dysregulated inflammatory response in UPS, causing either 
increased levels of circulating IL-6 or an increased sensitivity 
to IL-6.  Additionally, this hypothesis stresses the central role 
of IL-6 in the persistent fatigue experienced during UPS.
Apart from fatigue-inducing properties, IL-6 has many 
functions and a wide range of biological activities, such 
as support of erythropoeisis, regulation of immune system 
responses,20 and generation of acute-phase reactions.20 
Recent research suggests that IL-6 may also play a metabolic 
role inducing counterregulatory hormones, hepatic glucose 
output and lipolysis (reviewed elsewhere35,36).  Furthermore, 
IL-6 has been proposed as a glucose-regulator during 
prolonged exercise.45
IL-6 induces the sensation of fatigue at rest 
Studies investigating the effect of IL-6 on resting healthy in-
dividuals showed that low doses of recombinant human IL-6 
(rhIL-6, a synthesised form of IL-6) induce an increased sen-
sation of fatigue.3,44 In one study subjects were given either 
a single low dose of IL-6 that mimicked systemic increases in 
this cytokine typically observed during a moderate infection 
(and also comparable with those measured in athletes fol-
lowing prolonged exercise33), or a placebo.44 A self-reported 
mood state questionnaire was completed 3 hours after IL-
6 administration; scores showed that subjects were feeling 
significantly more tired compared with the placebo trial.  All 
signs and symptoms associated with the IL-6 administration 
had resumed pre-trial values when assessed 12 hours later. 
Although clinicians readily acknowledge the fatigue-inducing 
properties of IL-6,21,23,48 these properties have gone largely 
unrecognised by exercise physiologists.  
Exogenous IL-6 administration exacerbates fatigue in 
healthy trained runners during exercise
Recent data obtained from a performance-related study40 in-
dicate that IL-6 may also play a role in the sensation of fatigue 
during exercise.  When a dose of rhIL-6 was administered 
to subjects prior to a 10 km time trial (to induce equivalent 
plasma concentrations found following prolonged exercise or 
a moderate infection), subjects reported an increased sensa-
tion of physical and psychological fatigue during the exercise 
trial that ultimately resulted in a significant decrement in per-
formance. This led the researchers to suggest that IL-6 may 
also act as a circulating fatigue-inducing molecule during 
exercise.  Both global mood state and fatigue worsened as 
scores were significantly higher immediately post-exercise in 
the IL-6 trial compared with placebo. The effect of the IL-6 
treatment was relatively short-lived, as by approximately 3 
hours post-IL-6 administration, scores for global mood state 
and fatigue16 had returned to pre-treatment values.  It ap-
pears that transiently elevated levels of IL-6 negatively af-
fect the sensation of fatigue and global mood state in healthy 
runners.
Rating of perceived exertion5 was also measured 
throughout the exercise trials but was not different between 
trials despite the subjects running slower during the IL-6 trial 
(Robson-Ansley et al. – unpublished data, 2003).  This may 
be perceived as subjects running with the ‘same pain but 
less gain’ compared with the placebo trial.  Subjects felt they 
were running with the same effort but were, in fact, running 
significantly slower; some subjects reported that they could 
not get their legs moving and complained of ‘heavy legs’ 
during the exercise trial.  This is the first study to directly 
identify that an elevated plasma IL-6 concentration (similar 
to that measured following a prolonged bout of exercise) 
has fatigue-inducing properties that can affect both mood 
state and athletic performance, both of which are factors 
associated with UPS.  
Heightened sensitivity to IL-6 in chronic fatigue syn-
drome – the missing link in UPS?
UPS has several parallels with chronic fatigue syndrome 
(CFS), in particular persistent fatigue and mood disturbanc-
es,12 hence research findings on CFS may aid elucidation 
of the aetiology of UPS.  Resting plasma IL-6 levels appear 
similar between healthy athletes and UPS athletes,34 as well 
as between healthy individuals and CFS patients.  Whether 
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or not the IL-6 response to exercise differs between healthy 
and UPS athletes is currently undetermined. Although resting 
levels of IL-6 in healthy and chronically fatigued individuals 
may be comparable, recent research highlights the fact that 
CFS patients have a heightened sensitivity to IL-6 compared 
with normal, healthy individuals.3,15  Following IL-6 adminis-
tration, CFS patients experienced a greater number of so-
matic symptoms such as aches, fatigue and malaise, with 
a shorter latency, compared with the healthy controls.3 The 
feelings of fatigue and malaise remained up to 24 hours after 
the rhIL-6 administration in the CFS group.  Unfortunately, 
initial levels of IL-6 were not reported for the patients with 
CFS or normal control subjects, so it is not known whether 
CFS patients commenced the study with elevated plasma IL-
6 levels.  The cause of the abnormal/heightened response to 
rhIL-6 in CFS is unclear, but elucidation of this may provide 
insight into the chronic fatigue during exertion experienced by 
athletes with UPS.  
Heightened sensitivity to IL-6 in UPS
The IL-6 hypothesis39 proposes that time-dependent sen-
sitisation (TDS) to IL-6, similar to what has been proposed 
for CFS patients, could provide a model through which the 
aetiology of UPS may be explained.  TDS is described as a 
progressive and persistent amplification of behavioural and 
biochemical responses to repeated intermittent stimuli over 
time.4 The model proposes that a long-term or permanent 
physiological adaptation occurs as a consequence of initial 
exposure to a severe physical or psychological stimulus (or 
stimuli).  This results in the individual developing a progres-
sive and amplified intolerance on repeated exposure rather 
than developing a tolerance.  In accordance with the TDS 
model, the IL-6 hypothesis proposes that initial stressors or 
trigger factors for UPS such as severe infection,   47 excessive 
exercise, heat stroke8 or severe psychological stress25,26 
evoke a substantial cytokine response. These proposed trig-
ger factors may sensitise individuals in such a manner that 
they become sensitive to IL-6 and exercise-intolerant (mala-
dapting to the exercise stress), causing performance decre-
ments with each subsequent training session (Fig. 1).   
The exact physiological mechanism affected by the initial 
exposure to a severe stressor is unknown, but it is thought that 
stressors and/or the biochemical responses to the stressors 
could induce gene transcription factors.38 Activation of these 
gene transcription factors by exposure to a significant stressor 
could cause a long-term alteration of responsivity to future 
stressors, possibly by increasing cytokine receptor densities 
or soluble receptor concentrations.  In support of this, one 
study30 demonstrated that repeated exposure to stress 
induces changes in IL-6 mRNA and IL-6 receptor mRNA in 
the brain, which are different from those induced during a 
single exposure to stress.
Alternatively, the initial trigger factor(s) that stimulated 
the TDS may have caused permanent or long-term damage 
to the blood-brain barrier (BBB).  The integrity of the BBB 
permeability to cytokines can be altered by exposure to 
factors such as excessive cytokine exposure,11 heat stress49 
and endotoxins.24 It is conceivable that this increased 
permeability to cytokines may induce a heightened degree 
of ‘sickness behaviour’ and associated fatigue, upon a 
subsequent exposure that could be evoked by factors such 
as prolonged exercise.  
The IL-6 hypothesis of UPS suggests that the relentless 
fatigue experienced by these athletes is due to stimulation 
of certain CNS structures by an increase in or heightened 
sensitivity to IL-6.  Present research suggests that resting 
blood levels of IL-6 in UPS athletes are similar to levels in 
healthy controls; there is minimal evidence on post-exercise 
levels of IL-6 in UPS athletes.  The possibility of increased 
sensitivity to IL-6 was proposed as a possible explanation for 
the extreme fatigue experienced by these athletes.   
summary and conclusion
Two hypotheses were presented in this article in an attempt to 
explain the debilitating fatigue experienced during UPS.  The 
cytokine hypothesis43 stresses excessive training with result-
ant tissue damage and the potential role of several cytokines 
that could induce fatigue, and that are possibly associated 
with depression.  The IL-6 hypothesis39 focuses on a possi-
ble central role for this one cytokine, stressing multi-factorial 
causes of elevated IL-6 in UPS.  This hypothesis further sug-
gests that an increased sensitivity to IL-6 could be implicated 
in the extreme fatigue associated with UPS. 
However, to date there is limited information to support 
these hypotheses. Thus it is acknowledged that extensive 
animal and human studies are warranted to either support or 
refute these suppositions. 
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